FlowOx by Otivio

Otivio is a small medtech development company based in Oslo, Norway. Our vision is to stimulate active self care and treatment through simple and easy to use home treatment devices and services.

BIOGRAPHY

FlowOx by Otivio is a new direction in self healthcare

Otivio AS is a privately owned company based in Oslo, Norway. The company was founded in 2010 based on IP, prototypes and clinical data developed at University of Oslo. Otivio is ISO 13485 certified. Our main product FlowOx is a non-invasive medical device for home use addressing insufficient blood flow to the limbs assosciated with peripheral arterial disease, diabetes and other medical conditions. These conditions lead to pain, chronic wounds and amputations.

FlowOx is documented to reduce or eliminate these outcomes which represent a big impact on Quality of Life and health care costs. FlowOx represents a solution for transition from hospital to home treatment accentuated by the COVID-19 outbreak. FlowOx is CE marked and available in Germany, UK, Norway, Sweden and Denmark. Current sales trajectory validates the need for and value of FlowOx.

EMPLOYEES

Who are we at Otivio?

The management team of Otivio has, on average, more than 20 years of experience from the life science industry.

Andreas Mollatt
CEO

+47 934 46 261
am@otivio.com

Iacob Mathiesen
CSO

+47 468 90 416
im@otivio.com

Hans Petter Tjeldflaat
CFO

hpt@otivio.com

Claus Kjærsgaaard
CCO

+45 538 49 718
ck@otivio.com

Brian Alberts
Project and Logistic Coordinator

+47 (0) 930 05 210
ba@otivio.com

Ira Sankhayan
Head of QA/RA

+47 (0) 470 24 079
ira@otivio.com

Henrik Hoel
Clinical Researcher

hh@otivio.com

Jody McIntosh
Clinical Researcher

jm@otivio.com

Lynsey Adderley-Dey
Business Development Manager UK

+44 (0) 7311 821 833
lad@otivio.com

Tarwinder Singh
Office Administrator

+47 (0) 465 26 169
ts@otivio.com

Punit Patel
Quality Assurance Manager

+47 (0) 930 14 786
pp@otivio.com

About flowox

FlowOx in the Press

Otivio has developed FlowOx™ for patients suffering from the effects of PAD such as leg pain and chronic wounds. Early long-term testing documents increased blood flow.

The boots to save Grethe's legs

The doctors would amputate the leg of Grethe Valskaar Hetland. Then she got hold of these vacuum boots.

First RCT to show improved walking capacity

First multi-centre randomized controlled trial using FlowOx™, published in Journal of Vascular Surgery, shows improved walking capacity for patients with intermittent claudication, also known as “windows shopper’s disease”.

cooperative partners

With a Little Help

Otivio has a strong setup of partners and suppliers all the way from design, development and manufacturing to clinical documentation, sales and distribution.

Norway Health Tech

Oslo, Norway

Oslo Medtech is a health technology cluster, dedicated to accelerate and support the development of new medtech, eHealth products, services and innovative solutions for the Norwegian and global health care market.

Innokas Medical

Kempele, Finland

Innokas Medical have been producing health technology since 1994. They focus on design and manufacturing of medical equipment under the world’s leading brand names in accordance with their specific strategy and values.

Oslo University Hospital

Aker, Norway

The heart, lung and vascular clinic at Oslo University hospital is Scandinavia’s largest center for cardiovascular disease treatment.

H&R Healthcare

Melton, United Kingdom

Established near Hull in 2006, they represent world-class companies in the product areas of Advanced Wound Management, Compression, Infection Control and Skin Protection.

MediQ – Innovations Experts

Frankfurt, Germany

Mediq is a strategy and innovation consulting firm for the German and European healthcare market. We specialize in strategy development for technology and service innovations.